Searched for
GENERIC ANIMAL PHARMACEUTICALS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Fredun Pharmaceuticals board approves 2:1 bonus issueFredun Pharmaceuticals’ board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to r...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Strengthening the India-US medicines partnership important: IPAThe Indian Pharmaceutical Alliance welcomed an interim trade agreement between India and the US, emphasizing that medicine security is cruc...
- Zydus Lifesciences shares in focus on USFDA nod for canine drugShares of Zydus Lifesciences are likely in focus after its subsidiary, ZyVet Animal Health, launched the first FDA-approved generic treatme...
- Advent International to acquire stake in Felix PharmaceuticalsAdvent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin...
- Fundamental Radar: Why Zydus Lifesciences is poised for strong earnings growthHeadquartered in Ahmedabad, Zydus Lifesciences is present across the pharmaceutical value chain of research, development, manufacturing, ma...
- Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 crHyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...
- Buy Hikal, target Rs 218: HDFC SecuritiesBuy Hikal at a price target of Rs 218.
- Eight Roads leads Rs 45 crore Series A funding round in Ashish Life ScienceThe investment is the second by the marquee investor in India's broader pharmaceutical sector.
- Government to frame new rules on medical devices to draw investmentsIndia is the largest provider of generic drugs globally, with the Indian generics accounting for 20 per cent of global exports in terms of ...
- Transgene Biotek joins hands with Mauritius-based FII, to delist sharesTransgene Biotek has announced that Stream Value Fund has agreed to join hands on a long-term basis to support its drug discovery activity.
- Lupin settles litigation over Lunesta with Japanese firmDrug firm Lupin on Monday said it has settled ongoing litigation over Lunesta tablets, used in treating insomnia, with Japan-based Dainippo...
- Global drug cos set sights on India’s veterinary marketAnimal healthcare in India is no longer an afterthought, as global pharmaceutical companies facing loss in revenues due to expiring drug pa...
- Good days are here to stay for drug makersThe pharmaceutical sector, which has recorded a strong performance in the past two consecutive quarters, is again set to report strong numb...
Load More
